Default could shutter FDA reviews
Even if a debt crisis is averted, agency’s budget is under threat
FDA’s review of medical products could grind to a halt if Congress and President Joe Biden fail to agree on a formula for raising the debt ceiling in time to avoid a default, FDA Commissioner Rob Califf warned Wednesday. What he didn’t say is that regardless of how or when the crisis is resolved, FDA is almost certainly going to have to learn to live with less funding in the coming years.
Unlike a government shutdown, FDA may be prevented from spending user fees if there is a default. ...